Skip to main content

Advertisement

Log in

Male Genital Premalignant Dermatoses

  • Office Urology (N Shore, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

The spectrum of conditions affecting the penile skin is varied and ranges from simple, benign dermatoses to premalignant and malignant conditions. Recently, improved understanding of the aetiology and natural history of these conditions has shaped new treatment paradigms and a functional knowledge of dermatology, urology and genitourinary medicine is required to successfully diagnose and treat these men. In this article, we explore the common precancerous states that can lead to penile carcinoma and review the recent advances with regards to the molecular basis for these dermatoses and the treatments that may be most effective for these men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance•• Of major importance

  1. Hatzimouratidis K, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Salonia A, et al. EAU Guidelines on Penile Curvature. Eur Urol. 2012;62(3):543–52. doi:10.1016/j.eururo.2012.05.040.

    Article  PubMed  Google Scholar 

  2. Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, et al. Trauma, gender reassignment, and penile augmentation. J Sex Med. 2010;7(4 Pt 2):1657–67. doi:10.1111/j.1743-6109.2010.01781.x.

    Article  PubMed  Google Scholar 

  3. Morua AG, Lopez JA, Garcia JD, Montelongo RM, Guerra LS. Fournier's gangrene: our experience in 5 years, bibliographic review and assessment of the Fournier's gangrene severity index. Arch Esp Urol. 2009;62(7):532–40.

    PubMed  Google Scholar 

  4. Garaffa G, Christopher N, Ralph DJ. The management of genital lymphoedema. BJU Int. 2008;102(4):480–4. doi:10.1111/j.1464-410X.2008.07559.x.

    Article  PubMed  Google Scholar 

  5. Moon DG, Yoo JW, Bae JH, Han CS, Kim YK, Kim JJ. Sexual function and psychological characteristics of penile paraffinoma. Asian J Androl. 2003;5(3):191–4.

    PubMed  Google Scholar 

  6. Workowski KA, Berman S, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 2010;59(RR-12):1-110.

  7. Chaux A, Cubilla AL. The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas. Semin Diagn Pathol. 2012;29(2):67–71.

    Article  PubMed  Google Scholar 

  8. Koifman L, Vides AJ, Koifman N, Carvalho JP, Ornellas AA. Epidemiological aspects of penile cancer in Rio de Janeiro: evaluation of 230 cases. Int Braz J Urol: official J Braz Soc Urol. 2011;37(2):231–40. discussion 40-3.

    Article  Google Scholar 

  9. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer J Int Cancer. 2005;116(4):606–16. doi:10.1002/ijc.21009.

    CAS  Google Scholar 

  10. •• Kayes OJ, Loddo M, Patel N, Patel P, Minhas S, Ambler G, et al. DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma. Clin Cancer Res: official J Am Assoc Cancer Res. 2009;15(23):7335–44. doi:10.1158/1078-0432.CCR-09-0882. A new direction for molecular studies in penile cancer, exploring the role of genomic instability and cell cycle dysfunction in carcinogenesis and progression in penile cancer.

    Article  CAS  Google Scholar 

  11. Chaux A, Velazquez EF, Amin A, Soskin A, Pfannl R, Rodriguez IM, et al. Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: a pathological study of 139 lesions in 121 patients. Hum Pathol. 2012;43(7):1020–7. doi:10.1016/j.humpath.2011.07.025.

    Article  PubMed  Google Scholar 

  12. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes & Control: CCC. 2009;20(4):449–57. doi:10.1007/s10552-008-9276-9.

    Article  Google Scholar 

  13. Robinson D, Coupland V, Moller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer. 2009;100(3):527–31. doi:10.1038/sj.bjc.6604871.

    Article  PubMed  CAS  Google Scholar 

  14. Subhawong AP, Subhawong T, Nassar H, Kouprina N, Begum S, Vang R, et al. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol. 2009;33(2):163–75. doi:10.1097/PAS.0b013e31817f9790.

    Article  PubMed  Google Scholar 

  15. Bleeker MC, Hogewoning CJ, Van Den Brule AJ, Voorhorst FJ, Van Andel RE, Risse EK, et al. Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol. 2002;47(3):351–7.

    Article  PubMed  Google Scholar 

  16. •• Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, et al. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One. 2011;6(3):e17517. doi:10.1371/journal.pone.0017517. The first evidence of the distinct molecular dysregulation and potential for positive effect of agents targeting the HER3 receptor in a subset of penile cancers.

    Article  PubMed  CAS  Google Scholar 

  17. • Stankiewicz E, Prowse DM, Ktori E, Cuzick J, Ambroisine L, Zhang X, et al. The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma. Histopathology. 2011;58(3):433–9. doi:10.1111/j.1365-2559.2011.03762.x. Recent data to support a dichotomous process of early molecular changes driving carcinogenesis in penile cancer.

    Article  PubMed  Google Scholar 

  18. D'Hauwers KW, Depuydt CE, Bogers JJ, Noel JC, Delvenne P, Marbaix E, et al. Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium. Vaccine. 2012. doi:10.1016/j.vaccine.2012.08.034.

  19. Mannweiler S, Sygulla S, Beham-Schmid C, Razmara Y, Pummer K, Regauer S. Penile carcinogenesis in a low-incidence area: a clinicopathologic and molecular analysis of 115 invasive carcinomas with special emphasis on chronic inflammatory skin diseases. Am J Surg Pathol. 2011;35(7):998–1006. doi:10.1097/PAS.0b013e3182147e59.

    Article  PubMed  Google Scholar 

  20. Oertell J, Caballero C, Iglesias M, Chaux A, Amat L, Ayala E, et al. Differentiated precursor lesions and low-grade variants of squamous cell carcinomas are frequent findings in foreskins of patients from a region of high penile cancer incidence. Histopathology. 2011;58(6):925–33. doi:10.1111/j.1365-2559.2011.03816.x.

    Article  PubMed  Google Scholar 

  21. Porter WM, Francis N, Hawkins D, Dinneen M, Bunker CB. Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol. 2002;147(6):1159–65.

    Article  PubMed  CAS  Google Scholar 

  22. Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27(2):141–50. doi:10.1007/s00345-008-0302-z.

    Article  PubMed  CAS  Google Scholar 

  23. • Edmonds EV, Hunt S, Hawkins D, Dinneen M, Francis N, Bunker CB. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol: JEADV. 2012;26(6):730–7. doi:10.1111/j.1468-3083.2011.04155.x. A large series of patients with genital lichen sclerosus observed and newer, clinical hypotheses into aetiology and progression proposed.

    Article  PubMed  CAS  Google Scholar 

  24. Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br J Dermatol. 1983;109(6):661–4.

    Article  PubMed  CAS  Google Scholar 

  25. Purcell KG, Spencer LV, Simpson PM, Helman SW, Oldfather JW, Fowler Jr JF. HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol. 1990;126(8):1043–5.

    Article  PubMed  CAS  Google Scholar 

  26. Oyama N, Chan I, Neill SM, Hamada T, South AP, Wessagowit V, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet. 2003;362(9378):118–23. doi:10.1016/S0140-6736(03)13863-9.

    Article  PubMed  CAS  Google Scholar 

  27. Edmonds E, Barton G, Buisson S, Francis N, Gotch F, Game L, et al. Gene expression profiling in male genital lichen sclerosus. Int J Exp Pathol. 2011;92(5):320–5. doi:10.1111/j.1365-2613.2011.00779.x.

    Article  PubMed  CAS  Google Scholar 

  28. Chaux A, Pfannl R, Lloveras B, Alejo M, Clavero O, Lezcano C, et al. Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature. Am J Surg Pathol. 2010;34(3):385–92. doi:10.1097/PAS.0b013e3181cdad23.

    Article  PubMed  Google Scholar 

  29. Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000;86(4):459–65.

    Article  PubMed  CAS  Google Scholar 

  30. Pietrzak P, Hadway P, Corbishley CM, Watkin NA. Is the association between balanitis xerotica obliterans and penile carcinoma underestimated? BJU Int. 2006;98(1):74–6. doi:10.1111/j.1464-410X.2006.06213.x.

    Article  PubMed  Google Scholar 

  31. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353(9166):1777–83.

    Article  PubMed  CAS  Google Scholar 

  32. Perceau G, Derancourt C, Clavel C, Durlach A, Pluot M, Lardennois B, et al. Lichen sclerosus is frequently present in penile squamous cell carcinomas but is not always associated with oncogenic human papillomavirus. Br J Dermatol. 2003;148(5):934–8.

    Article  PubMed  CAS  Google Scholar 

  33. Velazquez EF, Cubilla AL. Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role. Am J Surg Pathol. 2003;27(11):1448–53.

    Article  PubMed  Google Scholar 

  34. • Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, et al. EAU penile cancer guidelines 2009. Eur Urol. 2010;57(6):1002–12. doi:10.1016/j.eururo.2010.01.039. Contemporary management guidelines from the office of the European Association of Urology.

    Article  PubMed  Google Scholar 

  35. Abdelbaky AM, Aluru P, Keegan P, Greene DR. Development of male genital lichen sclerosus in penile reconstruction skin grafts after cancer surgery: an unreported complication. BJU Int. 2012;109(5):776–9. doi:10.1111/j.1464-410X.2011.10368.x.

    Article  PubMed  Google Scholar 

  36. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. PharmacoEconomics. 2005;23(11):1107–22.

    Article  PubMed  Google Scholar 

  37. Anic GM, Lee JH, Stockwell H, Rollison DE, Wu Y, Papenfuss MR, et al. Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis. 2011;204(12):1886–92. doi:10.1093/infdis/jir652.

    Article  PubMed  Google Scholar 

  38. Noel JC, Vandenbossche M, Peny MO, Sassine A, de Dobbeleer G, Schulman CC, et al. Verrucous carcinoma of the penis: importance of human papillomavirus typing for diagnosis and therapeutic decision. Eur Urol. 1992;22(1):83–5.

    PubMed  CAS  Google Scholar 

  39. Solivan GA, Smith KJ, James WD. Cutaneous horn of the penis: its association with squamous cell carcinoma and HPV-16 infection. J Am Acad Dermatol. 1990;23(5 Pt 2):969–72.

    Article  PubMed  CAS  Google Scholar 

  40. Schellhammer PF, Jordan GH, Robey EL, Spaulding JT. Premalignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum. Urol Clin N Am. 1992;19(1):131–42.

    CAS  Google Scholar 

  41. Gray MR, Ansell ID. Pseudo-epitheliomatous hyperkeratotic and micaceous balanitis: evidence for regarding it as pre-malignant. Br J Urol. 1990;66(1):103–4.

    Article  PubMed  CAS  Google Scholar 

  42. Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int. 2004;94(9):1253–7. doi:10.1111/j.1464-410X.2004.05153.x.

    Article  PubMed  Google Scholar 

  43. Minhas S, Kayes O, Hegarty P, Kumar P, Freeman A, Ralph D. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96(7):1040–3. doi:10.1111/j.1464-410X.2005.05769.x.

    Article  PubMed  Google Scholar 

  44. Li J, Zhu Y, Zhang SL, Wang CF, Yao XD, Dai B, et al. Organ-sparing surgery for penile cancer: complications and outcomes. Urology. 2011;78(5):1121–4. doi:10.1016/j.urology.2011.08.006.

    Article  PubMed  Google Scholar 

  45. •• Philippou P, Shabbir M, Malone P, Nigam R, Muneer A, Ralph DJ, et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol. 2012;188(3):803–8. doi:10.1016/j.juro.2012.05.012. Organ-sparing surgery should be considered the standard of care for appropriately selected patients based on data from this update on a large series of patients treated in a single centre in the UK.

    Article  PubMed  Google Scholar 

  46. Hadway P, Corbishley CM, Watkin NA. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int. 2006;98(3):532–6. doi:10.1111/j.1464-410X.2006.06368.x.

    Article  PubMed  Google Scholar 

  47. Shabbir M, Muneer A, Kalsi J, Shukla CJ, Zacharakis E, Garaffa G, et al. Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol. 2011;59(1):142–7. doi:10.1016/j.eururo.2010.09.039.

    Article  PubMed  Google Scholar 

  48. Goette DK, Elgart M, DeVillez RL. Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. JAMA: J Am Med Assoc. 1975;232(9):934–7.

    Article  CAS  Google Scholar 

  49. Alnajjar HM, Lam W, Bolgeri M, Rees RW, Perry MJ, Watkin NA. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol. 2012. doi:10.1016/j.eururo.2012.02.052.

  50. •• Batista CS, Atallah AN, Saconato H, da Silva EM. 5-FU for genital warts in non-immunocompromised individuals. Cochrane Database Syst Rev. 2010;4:CD006562. doi:10.1002/14651858.CD006562.pub2. Level one evidence to support the use of individual topical agents in the treatment of genital warts at risk of malignant conversion.

    PubMed  Google Scholar 

  51. Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, et al. Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int. 2010;106(6):786–90. doi:10.1111/j.1464-410X.2009.09188.x.

    Article  PubMed  Google Scholar 

  52. Hansen JP, Drake AL, Walling HW. Bowen's Disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg: official publication Am Soc Dermatol Surg [et al]. 2008;34(7):878–83. doi:10.1111/j.1524-4725.2008.34172.x.

    Article  CAS  Google Scholar 

  53. Fai D, Romano I, Cassano N, Vena GA. Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients. J Dermatol Treat. 2011. doi:10.3109/09546634.2011.577405.

  54. Feldmeyer L, Krausz-Enderlin V, Tondury B, Hafner J, French LE, Hofbauer GF. Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat. Dermatology. 2011;223(1):52–6. doi:10.1159/000330328.

    Article  PubMed  CAS  Google Scholar 

  55. • Schlenker B, Gratzke C, Seitz M, Bader MJ, Reich O, Schneede P, et al. Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up. Urol Oncol. 2011;29(6):788–93. doi:10.1016/j.urolonc.2009.10.001. The authors are enthusiasts for this novel technique and share their experiences which support developing larger, multicentre studies to prove the conclusions proposed in this paper.

    Article  PubMed  Google Scholar 

  56. Hakim AA, Lin PS, Wilczynski S, Nguyen K, Lynes B, Wakabayashi MT. Indications and efficacy of the human papillomavirus vaccine. Curr Treat Options Oncol. 2007;8(6):393–401. doi:10.1007/s11864-007-0050-0.

    Article  PubMed  Google Scholar 

  57. Centers for Disease C, Prevention. Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012;61:258–61.

    Google Scholar 

  58. •• Brisson M, Van de Velde N, Boily MC. Economic evaluation of human papillomavirus vaccination in developed countries. Publ Health Genome. 2009;12(5–6):343–51. doi:10.1159/000214924. HPV vaccination remains a contentious topic amongst clinicians working in this field. Clearer guidance can be sourced in this recent release from the CDC and the impact of male vaccination is expertly discussed.

    Article  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oliver Kayes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kayes, O., Shabbir, M. & Minhas, S. Male Genital Premalignant Dermatoses. Curr Urol Rep 13, 488–495 (2012). https://doi.org/10.1007/s11934-012-0284-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-012-0284-7

Keywords

Navigation